Must be time for an update on how they are tracking on achieving this third leg. You'de think there would be some kind of time frame attached.
Printable View
Hmmm.... You sure about the fact that this has not been delieved on.... ?
This is from their Interim Report from 19 December...:
"Completion of two of the three milestones required for US reimbursement, being receipt of product codes and notification of a national price (US$760 per test)." (My highlight)....
Annual results are announced towards the end of May and usually there's some kind of announcement a week or so earlier just to whet everyone's appetite and to give Balance another bone to chew on.
Let's wait till then - after all we've been waiting a bloody long time for some positive news of real significance.
Meantime we can enjoy more tedious repetitive updates from our resident expert on share prices.
You have. But that is despite the vitriolic and marginally abusive tone of many of your posts rather than because of it. Referring to "Sucker instos" (for example) is neither respectful nor informative, and doesn't encourage other people to engage with you about the issues.
Fair enough but how else would you describe institutions ignoring the numerous red flags hoisted by PEB and pumping in ever more money (other people's monies) at ever decreasing share prices? Is 'sucker' an apt description and hence, informative to those who may be inclined to think that institutions are superior investors vs them?
And do please note that I did not refer to anyone on this forum as 'suckers' etc - only the institutions who are supposed to do comprehensive research, have better access to superior information and cewrtainly, superior access to the company and management.
And yes, I have very little respect for the institutions who has showed that they have not exacted accountability from PEB, and DD in particular for the numerous missed deadlines, and the infamous non-sales saga.